No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 60 contracts
Sources: Securities Purchase Agreement (Heron Therapeutics, Inc. /De/), Securities Purchase Agreement (Rubric Capital Management LP), Stock Purchase Agreement (Zymeworks Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (Ai) in writing by the Commission or the Principal Trading Market or (Bii) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 18 contracts
Sources: Securities Purchase Agreement (Minerva Neurosciences, Inc.), Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Ventyx Biosciences, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock (i) shall be designated for listing or quotation on the Principal Trading Market and (ii) shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the any minimum listing maintenance requirements of the Principal Trading Market.
Appears in 9 contracts
Sources: Securities Purchase Agreement (Mri Interventions, Inc.), Securities Purchase Agreement (Mri Interventions, Inc.), Securities Purchase Agreement (Mri Interventions, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 6 contracts
Sources: Stock Purchase Agreement (NKGen Biotech, Inc.), Collaboration Agreement (NKGen Biotech, Inc.), Stock Purchase Agreement (NKGen Biotech, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission SEC or the Principal Trading Market Nasdaq from trading on the Principal Trading Market Nasdaq nor shall suspension by the Commission SEC or the Principal Trading Market Nasdaq have been threatened, as of the Closing Date, either (Ai) in writing by the Commission SEC or the Principal Trading Market Nasdaq or (Bii) by falling below the minimum listing maintenance requirements of the Principal Trading MarketNasdaq.
Appears in 5 contracts
Sources: Research Collaboration and License Agreement, Research Collaboration and License Agreement (Five Prime Therapeutics Inc), Research Collaboration and License Agreement (Five Prime Therapeutics Inc)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market OTCQB from trading on the Principal Trading Market OTCQB nor shall suspension by the Commission or the Principal Trading Market OTCQB have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market OTCQB or (B) by falling below the minimum listing maintenance requirements of the Principal Trading MarketOTCQB.
Appears in 5 contracts
Sources: Securities Purchase Agreement (MetaStat, Inc.), Note Purchase Agreement (MetaStat, Inc.), Note and Warrant Purchase Agreement (Fluoropharma Medical, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (Ai) in writing by the Commission or the Principal Trading Market or (Bii) by falling below the minimum listing maintenance requirements of the Principal Trading Market, except as disclosed on Schedule 3.1(y).
Appears in 2 contracts
Sources: Securities Purchase Agreement (Unicycive Therapeutics, Inc.), Securities Purchase Agreement (Unicycive Therapeutics, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock (i) shall be designated for listing and quotation on the Principal Trading Market and (ii) shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing DateDate other than as set forth in the SEC Reports, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 2 contracts
Sources: Securities Purchase Agreement (MetaVia Inc.), Securities Purchase Agreement (NeuroBo Pharmaceuticals, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission SEC or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission SEC or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission SEC or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Eloxx Pharmaceuticals, Inc.), Common Stock Purchase Agreement (Aveo Pharmaceuticals Inc)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 2 contracts
Sources: Securities Purchase Agreement (Fate Therapeutics Inc), Securities Purchase Agreement (Fate Therapeutics Inc)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date (or the Subsequent Closing Date), by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date (or Subsequent Closing Date), either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the or prior to any Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the or prior to any applicable Closing Date, either (Ai) in writing by the Commission or the Principal Trading Market or (Bii) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) Date in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading MarketCommission.
Appears in 1 contract
Sources: Securities Purchase Agreement (Cellectar Biosciences, Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing DateDate (or the applicable closing date of a Subsequent Closing), by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing DateDate (or the applicable closing date of a Subsequent Closing), either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission SEC or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission SEC or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market OTCBB from trading on the Principal Trading Market OTCBB nor shall suspension by the Commission or the Principal Trading Market OTCBB have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market OTCBB or (B) by falling below the minimum listing maintenance requirements of the Principal Trading MarketOTCBB.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, suspended by the Commission SEC or the Principal Trading Market from trading on the Principal Trading Market nor shall such suspension have been threatened by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
Sources: Securities Purchase Agreement (Scientific Learning Corp)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading MarketCommission.
Appears in 1 contract
Sources: Subscription Agreement (Organogenesis Holdings Inc.)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the applicable Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the applicable Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
Sources: Securities Purchase Agreement (Anthera Pharmaceuticals Inc)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission or the Principal principal Trading Market from trading on the Principal principal Trading Market nor shall suspension by the Commission or the Principal principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal principal Trading Market.
Appears in 1 contract
Sources: Securities Purchase Agreement (Z Trim Holdings, Inc)
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the each applicable Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the each applicable Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Parent Common Stock shall not have been suspended, as of the Closing Date, by the Commission SEC or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission SEC or the Principal Trading Market have been threatened, as of the Closing Date, either (Aa) in writing by the Commission SEC or the Principal Trading Market or (Bb) by falling below the minimum listing maintenance requirements of the Principal Trading Market.
Appears in 1 contract
No Suspensions of Trading in Common Stock. The Common Stock shall not have been suspended, as of the such Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal Trading Market have been threatened, as of the such Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market, if any.
Appears in 1 contract
Sources: Securities Purchase Agreement (Guided Therapeutics Inc)
No Suspensions of Trading in Common Stock. The trading of the Common Stock shall not have been suspended, as of the Closing Date, by the Commission SEC or any securities commission, stock exchange or any other regulatory authority in any jurisdiction and no such proceeding is, to the Principal Trading Market from trading on knowledge of the Principal Trading Market nor shall suspension by the Commission Company, pending, contemplated or the Principal Trading Market have been threatened, as . As of the Closing Date, either (A) in writing by the Commission or Common Stock shall be quoted for trading on the Principal Trading Market or (B) by falling below the minimum listing maintenance requirements of the Principal Trading MarketOTC Bulletin Board.
Appears in 1 contract
Sources: Subscription, Purchase and Investment Agreement (GlobalOptions Group, Inc.)